CYP19A1 and Other metabolic disease: These results suggest that EA could impact P450arom and P450c17α as well as the expression of their mRNA in PCOS ovarian tissues, thereby changing the local ovarian environment of excessive androgen and improving the reproductive, endocrine, and metabolic disorders associated with PCOS.